CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Grant or award Director acquired 842 shares (grant or award)
- 4 Grant or award Director acquired 1,497 shares (grant or award)
- 4 Open-market sale Chief Discovery Officer sold 31,515 shares at $13.88 ($437,428)
- 4 Grant or award Director acquired 404 shares (grant or award)
- 4 Grant or award Director acquired 809 shares (grant or award)
- 4 Grant or award Director acquired 1,438 shares (grant or award)
- 4 Grant or award Director acquired 404 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 12,866 shares (grant or award)
- 4 Grant or award Director acquired 569 shares (grant or award)
- 4 Grant or award Director acquired 1,138 shares (grant or award)
Page 9 of 49 · 965 filings